Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 2/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | RGS4 | P49798 | 1/20 | 0.32 |
| ▸ | RGS8 | P57771 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14094214 | 0.90 | ALDH1A1 (0.42) | ALDH1A1SCN9ABCHEACHEGRM5 | |
| SCHEMBL4185379 | 0.83 | DRD3 (0.34) | BCHEACHE | |
| SCHEMBL14094220 | 0.82 | ALDH1A1 (0.39) | ALDH1A1SCN9AGRM5PARP1RGS4 | |
| SCHEMBL4194219 | 0.81 | ALDH1A1 (0.36) | ALDH1A1SCN9ABCHEACHEGRM5 | |
| SCHEMBL10851567 | 0.81 | SCN9A (0.38) | ALDH1A1SCN9ABCHEACHEGRM5 | |
| SCHEMBL4189770 | 0.81 | ALDH1A1 (0.36) | ALDH1A1SCN9APARP1RGS4RGS8 | |
| SCHEMBL751330 | 0.80 | ALDH1A1 (0.38) | ALDH1A1SCN9AGRM5PARP1RGS4 | |
| SCHEMBL10956717 | 0.78 | CYP1A1 (0.41) | ALDH1A1BCHEACHE | |
| SCHEMBL7720084 | 0.77 | ALDH1A1 (0.36) | ALDH1A1SCN9APARP1RGS4RGS8 | |
| SCHEMBL4194394 | 0.77 | SCN9A (0.36) | ALDH1A1SCN9ABCHEACHEPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361246-B1 | ORGANIC POLYMER AND NOVEL POLYMERIZABLE COMPOUND | MITSUI CHEMICALS INC (JP) | 2009-02-18 | — | — | EP | disclosed |
| US-6797805-B2 | Organic polymers and novel polymerizable compounds | MITSUI CHEMICALS, INC. (JP) | 2004-09-28 | — | — | US | disclosed |
| EP-1361246-A1 | ORGANIC POLYMER AND NOVEL POLYMERIZABLE COMPOUND | Mitsui Chemicals, Inc. (JP) | 2003-11-12 | — | — | EP | disclosed |
| US-20030166808-A1 | Organic polymers and novel polymerizable compound | MITSUI CHEMICALS, INC. (JP) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166808-A1 | Organic polymers and novel polymerizable compound | PCNA, UTP18, ODC1 | ALDH1A1 4350/4885SCN9A 3491/4885BCHE 2722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.